Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,287 full-time employees. The firm is engaged in the manufacture and sale of prescription and over-the-counter drugs. The firm has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Ono Pharmaceutical Co Ltd Información sobre dividendos
Ono Pharmaceutical Co Ltd tiene un dividendo anual de 0.56 por acción, con un rendimiento del 0.00%. El dividendo se paga semestralmente y la última fecha ex-dividendo fue Sep 29, 2025.